Merck KGaA
MKGAF
$143.70
-$1.66-1.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.06% | 36.13% | -13.28% | 19.42% | -21.57% |
| Total Depreciation and Amortization | -20.96% | 2.60% | -2.38% | 26.81% | -17.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 329.40% | -93.62% | 2,567.67% | -213.44% | 113.88% |
| Change in Net Operating Assets | -86.45% | 145.56% | -297.55% | -1,647.82% | -104.30% |
| Cash from Operations | -18.14% | 72.96% | -17.52% | -0.89% | -17.01% |
| Capital Expenditure | 13.25% | -47.39% | 40.09% | -3.20% | -18.09% |
| Sale of Property, Plant, and Equipment | -143.09% | 206.42% | -45.92% | 1,009.18% | -75.27% |
| Cash Acquisitions | 61.50% | -- | -- | -- | 67.03% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.27% | -357.54% | 251.70% | -397.63% | -26.11% |
| Cash from Investing | 63.85% | -5,681.15% | 95.68% | -54.05% | -27.46% |
| Total Debt Issued | 86.68% | -1.36% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -100.00% | 96.55% | -688.61% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -1,764.75% | -- | -- |
| Other Financing Activities | 13,900.00% | 90.00% | -- | -- | 200.00% |
| Cash from Financing | -266.18% | 306.27% | -233.58% | 88.92% | -219.01% |
| Foreign Exchange rate Adjustments | 124.24% | -145.14% | -147.87% | 83.19% | -693.48% |
| Miscellaneous Cash Flow Adjustments | -3.04% | 202.15% | -199.14% | 0.84% | 198.92% |
| Net Change in Cash | -231.18% | 4.56% | 93.71% | 162.66% | -162.72% |
